7 research outputs found

    Removal of Lead Ions and Turbidity from Waste Water by Adsorbent Materials Derived from Cactus Leaves

    Get PDF
    The current work explores simple ways of developing cheap adsorbents materials from Cactus, a plant easily found in dry and semi-arid regions for use in water purification. The adsorption capacity and efficacy of its biomass, charcoal, ash and ash residue in removal of lead ions and turbidity from contaminated water is reported. The biomass was obtained by drying and grinding dry leaves to powder. Ash was obtained by heating the dry leaves in a furnace while the residue was obtained by dissolving and removing the soluble fraction. The charcoal was prepared by heating dry cactus leaves in a furnace in limited air. Batch experiments were carried out to determine the effect of initial concentration, PH, contact time, temperature and adsorbent dose on percentage removal of Pb2+ and turbidity. The data for Pb2+adsorption on ash residue was found to best fit in the Langmuir isotherm model while biomass, charcoal and ash data best fitted in the Freundlich model. Adsorption capacities for lead ions on ash residue, ash, charcoal and biomass were 1000.0000, 173.6201, 13.3352 and 3.1696mg/g respectively. The findings showed that the adsorbents are effective in removal of turbidity and lead (II) ions from contaminated water. Keywords: "lead", "Adsorption", "isotherms", "cactus", "green adsorbents

    Repellency and composition of essential oils of selected ethnobotanical plants used in Western Kenya against bites of Anopheles gambiae Sensu Stricto

    Get PDF
    The essential oils of Ocimum gratissimum Linn, Hyptis suaveolens (L) Poit and Vitex keniensis, which are used traditionally in Western Kenya for personal and space protection against mosquito bites, were screened for repellence against Anopheles gambiae Sensu Stricto. Essential oils were extracted from their leaves by hydrodistillation, characterised by gas chromatography linked with mass spectrophotometer and electroantennogram detectors. The repellency of the oils and their selected blends was studied by the reduction in probing and feeding on the human arm. The oils showed promising repellency for Anopheles gambiae, O. gratissimum (RD50 = 2.77 × 10-5 mg cm-2, 95% CI), Vitex keniensis (RD = 5.68 × 10-5 mg cm-2) and Hyptis suaveolens (6.27× 10-5 mg cm-2) as compared to that of DEET (control) RD = 1.25×10-5 mg cm-2). The bioactive constituents of each oil were identified by Gas chromatography-linked with Mass spectrometry and Electroantennography. Some compounds were confirmed by co-injections of the oil with available authentic standards. The results provide a scientific rationale for the traditional use of these plants in repelling disease vectors and other biting insects, and lay down some useful groundwork for downstream development of more effective products for personal and space protection

    Characterization of a composite with enhanced attraction to savannah tsetse flies from constituents or analogues of tsetse refractory waterbuck (Kobus defassa) body odor.

    No full text
    Savannah tsetse flies avoid flying toward tsetse fly-refractory waterbuck (Kobus defassa) mediated by a repellent blend of volatile compounds in their body odor comprised of Ύ-octalactone, geranyl acetone, phenols (guaiacol and carvacrol), and homologues of carboxylic acids (C5-C10) and 2-alkanones (C8-C13). However, although the blends of carboxylic acids and that of 2-alkanones contributed incrementally to the repellency of the waterbuck odor to savannah tsetse flies, some waterbuck constituents (particularly, nonanoic acid and 2-nonanone) showed significant attractive properties. In another study, increasing the ring size of Ύ-octalactone from six to seven membered ring changed the activity of the resulting molecule (Δ-nonalactone) on the savannah tsetse flies from repellency to attraction. In the present study, we first compared the effect of blending Δ-nonalactone, nonanoic acid and 2-nonanone in 1:1 binary and 1:1:1 ternary combination on responses of Glossina pallidipes and Glossina morsitans morsitans tsetse flies in a two-choice wind tunnel. The compounds showed clear synergistic effects in the blends, with the ternary blend demonstrating higher attraction than the binary blends and individual compounds. Our follow up laboratory comparisons of tsetse fly responses to ternary combinations with different relative proportions of the three components showed that the blend in 1:3:2 proportion was most attractive relative to fermented cow urine (FCU) to both tsetse species. In our field experiments at Shimba Hills game reserve in Kenya, where G. pallidipes are dominant, the pattern of tsetse catches we obtained with different proportions of the three compounds were similar to those we observed in the laboratory. Interestingly, the three-component blend in 1:3:2 proportion when released at optimized rate of 13.71mg/h was 235% more attractive to G. pallidipes than a combination of POCA (3-n-Propylphenol, 1-Octen-3-ol, 4-Cresol, and Acetone) and fermented cattle urine (FCU). This constitutes a novel finding with potential for downstream deployment in bait technologies for more effective control of G. pallidipes, G. m. morsitans, and perhaps other savannah tsetse fly species, in 'pull' and 'pull-push' tactics

    Enhanced infection prophylaxis reduces mortality in severely immunosuppressed HIV-infected adults and older children initiating antiretroviral therapy in Kenya, Malawi, Uganda and Zimbabwe: the REALITY trial

    Get PDF
    Meeting abstract FRAB0101LB from 21st International AIDS Conference 18–22 July 2016, Durban, South Africa. Introduction: Mortality from infections is high in the first 6 months of antiretroviral therapy (ART) among HIV‐infected adults and children with advanced disease in sub‐Saharan Africa. Whether an enhanced package of infection prophylaxis at ART initiation would reduce mortality is unknown. Methods: The REALITY 2×2×2 factorial open‐label trial (ISRCTN43622374) randomized ART‐naïve HIV‐infected adults and children >5 years with CD4 <100 cells/mm3. This randomization compared initiating ART with enhanced prophylaxis (continuous cotrimoxazole plus 12 weeks isoniazid/pyridoxine (anti‐tuberculosis) and fluconazole (anti‐cryptococcal/candida), 5 days azithromycin (anti‐bacterial/protozoal) and single‐dose albendazole (anti‐helminth)), versus standard‐of‐care cotrimoxazole. Isoniazid/pyridoxine/cotrimoxazole was formulated as a scored fixed‐dose combination. Two other randomizations investigated 12‐week adjunctive raltegravir or supplementary food. The primary endpoint was 24‐week mortality. Results: 1805 eligible adults (n = 1733; 96.0%) and children/adolescents (n = 72; 4.0%) (median 36 years; 53.2% male) were randomized to enhanced (n = 906) or standard prophylaxis (n = 899) and followed for 48 weeks (3.8% loss‐to‐follow‐up). Median baseline CD4 was 36 cells/mm3 (IQR: 16–62) but 47.3% were WHO Stage 1/2. 80 (8.9%) enhanced versus 108(12.2%) standard prophylaxis died before 24 weeks (adjusted hazard ratio (aHR) = 0.73 (95% CI: 0.54–0.97) p = 0.03; Figure 1) and 98(11.0%) versus 127(14.4%) respectively died before 48 weeks (aHR = 0.75 (0.58–0.98) p = 0.04), with no evidence of interaction with the two other randomizations (p > 0.8). Enhanced prophylaxis significantly reduced incidence of tuberculosis (p = 0.02), cryptococcal disease (p = 0.01), oral/oesophageal candidiasis (p = 0.02), deaths of unknown cause (p = 0.02) and (marginally) hospitalisations (p = 0.06) but not presumed severe bacterial infections (p = 0.38). Serious and grade 4 adverse events were marginally less common with enhanced prophylaxis (p = 0.06). CD4 increases and VL suppression were similar between groups (p > 0.2). Conclusions: Enhanced infection prophylaxis at ART initiation reduces early mortality by 25% among HIV‐infected adults and children with advanced disease. The pill burden did not adversely affect VL suppression. Policy makers should consider adopting and implementing this low‐cost broad infection prevention package which could save 3.3 lives for every 100 individuals treated
    corecore